Ratte IgG2b,kappa Isotyp-Kontrolle

Details zu Produkt Nr. ABIN2656485, Anbieter: Anmelden zum Anzeigen
Klonalität (Klon)
Monoklonal ()
Immunofluorescence (IF), Isotype Control (IsoC), Western Blotting (WB)
Anmelden zum Anzeigen
Hersteller Produkt- Nr.
Anmelden zum Anzeigen
Klon RTK4530
Isotyp IgG2b kappa
Produktmerkmale The isotype of RTK4530 immunoglobulin is rat IgG2b, κ. This antibody was chosen as an isotype control after screening on a variety of resting, activated, live, and fixed mouse, rat and human tissues.
Reinigung The immunoglobulin was purified by affinity chromatography, and conjugated with PerCP/Cy5.5 under optimal conditions. The solution is free of unconjugated PerCP/Cy5.5 and unconjugated immunoglobulin.
Andere Bezeichnung IgG2b kappa
Applikationshinweise Optimal working dilution should be determined by the investigator.
Beschränkungen Nur für Forschungszwecke einsetzbar
Konzentration 0.2 mg/mL
Buffer Phosphate-buffered solution, pH 7.2, containing 0.09 % sodium azide.
Konservierungsmittel Sodium azide
Vorsichtsmaßnahmen This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Handhabung Protect from prolonged exposure to light. Do not freeze.
Lagerung 4 °C
Informationen zur Lagerung The antibody solution should be stored undiluted between 2°C and 8°C.
Allgemeine Veröffentlichungen Schaefer, Montufar-Solis, Vigneswaran, Klein: "ICOS promotes IL-17 synthesis in colonic intraepithelial lymphocytes in IL-10-/- mice." in: Journal of leukocyte biology, Vol. 87, Issue 2, pp. 301-8, 2010 (PubMed).

Yi, Yu, Gao, Wang, Baek, Chen, Kim, Subjeck, Wang: "Pattern recognition scavenger receptor SRA/CD204 down-regulates Toll-like receptor 4 signaling-dependent CD8 T-cell activation." in: Blood, Vol. 113, Issue 23, pp. 5819-28, 2009 (PubMed).

Duan, Avci, Kasper: "Microbial carbohydrate depolymerization by antigen-presenting cells: deamination prior to presentation by the MHCII pathway." in: Proceedings of the National Academy of Sciences of the United States of America, Vol. 105, Issue 13, pp. 5183-8, 2008 (PubMed).

Sasaki, Zhao, Pardee, Ueda, Fujita, Sehra, Kaplan, Kane, Okada, Storkus: "Stat6 signaling suppresses VLA-4 expression by CD8+ T cells and limits their ability to infiltrate tumor lesions in vivo." in: Journal of immunology (Baltimore, Md. : 1950), Vol. 181, Issue 1, pp. 104-8, 2008 (PubMed).

Cervantes-Barragan, Züst, Weber, Spiegel, Lang, Akira, Thiel, Ludewig: "Control of coronavirus infection through plasmacytoid dendritic-cell-derived type I interferon." in: Blood, Vol. 109, Issue 3, pp. 1131-7, 2007 (PubMed).

Zeiser, Nguyen, Hou, Beilhack, Zambricki, Buess, Contag, Negrin: "Early CD30 signaling is critical for adoptively transferred CD4+CD25+ regulatory T cells in prevention of acute graft-versus-host disease." in: Blood, Vol. 109, Issue 5, pp. 2225-33, 2007 (PubMed).